Shilpa Biologicals and mAbTree Biologics Secure Orphan Drug Designation from U.S. FDA
19 March 2026
No Comments
Marks significant milestone for breakthrough biologic to treat rare blood cancers Basel, Switzerland and
Tag: mAbTree Biologics